Emerging roles for calcium-regulating hormones beyond osteolysis

被引:8
作者
Goltzman, David [1 ,2 ]
机构
[1] McGill Univ, Dept Med, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
VITAMIN-D-RECEPTOR; PTH-RELATED-PROTEIN; RENIN-ANGIOTENSIN SYSTEM; MINERAL ION HOMEOSTASIS; PARATHYROID-HORMONE; 1,25-DIHYDROXYVITAMIN D-3; NUCLEAR-LOCALIZATION; SKELETAL DEVELOPMENT; PTH/PTHRP RECEPTOR; GENETIC MODELS;
D O I
10.1016/j.tem.2010.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parathyroid hormone (PTH), the active form of vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)(2)D], and PTH-related peptide (PTHrP), the mediator of hypercalcemia of malignancy, are all osteolytic hormones. Recent studies have demonstrated that endogenous PTH and PTHrP also exert bone anabolic activity and that PTHrP is a crucial modulator of growth plate development. At least part of these PTHrP functions can be mediated by intracrine effects, involving a unique interplay of cell surface membrane and intracellular signaling. 1,25(OH)(2)D also exerts bone anabolic effects and, as with PTHrP, acts on multiple extraskeletal tissues. The skeletal functions of these hormones now extend beyond modulating bone resorption, and important extraskeletal activities have been discovered which involve unique local modes of action.
引用
收藏
页码:512 / 518
页数:7
相关论文
共 68 条
  • [1] Extracellular calcium regulates parathyroid hormone-related peptide expression in osteoblasts and osteoblast progenitor cells
    Ahlstrom, Mikael
    Pekkinen, Minna
    Riehle, Ulrike
    Lamberg-Allardt, Christel
    [J]. BONE, 2008, 42 (03) : 483 - 490
  • [2] Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials
    Autier, Philippe
    Gandini, Sara
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) : 1730 - 1737
  • [3] Vitamin D insufficiency: implications for the immune system
    Baeke, Femke
    Gysemans, Conny
    Korf, Hannelie
    Mathieu, Chantal
    [J]. PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1597 - 1606
  • [4] Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
    Bellido, T
    Ali, AA
    Gubrij, I
    Plotkin, LI
    Fu, Q
    O'Brien, CA
    Manolagas, SC
    Jilka, RL
    [J]. ENDOCRINOLOGY, 2005, 146 (11) : 4577 - 4583
  • [5] SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
    Bezooijen, RL
    ten Dijke, P
    Papapoulos, SE
    Löwik, CWGM
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (03) : 319 - 327
  • [6] Nonclassic Actions of Vitamin D
    Bikle, Daniel
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) : 26 - 34
  • [7] Bouillon R, 2008, J BONE MINER RES, V23, P974, DOI [10.1359/jbmr.080420, 10.1359/JBMR.080420]
  • [8] Extracellular calcium sensing and extracellular calcium signaling
    Brown, EM
    MacLeod, RJ
    [J]. PHYSIOLOGICAL REVIEWS, 2001, 81 (01) : 239 - 297
  • [9] Initial characterization of PTH-related protein gene-driven lacZ expression in the mouse
    Chen, XS
    Macica, CM
    Dreyer, BE
    Hammond, VE
    Hens, JR
    Philbrick, WM
    Broadus, AE
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (01) : 113 - 123
  • [10] Parathyroid hormone-related protein and its receptors:: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets
    Clemens, TL
    Cormier, S
    Eichinger, A
    Endlich, K
    Fiaschi-Taesch, N
    Fischer, E
    Friedman, PA
    Karaplis, AC
    Massfelder, T
    Rossert, J
    Schlüter, KD
    Silve, C
    Stewart, AF
    Takane, K
    Helwig, JJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) : 1113 - 1136